Natalie Larson, | |
1715 Dousman St, Green Bay, WI 54303-3211 | |
(920) 496-4700 | |
Not Available |
Full Name | Natalie Larson |
---|---|
Gender | Female |
Speciality | Certified Nurse Midwife (cnm) |
Experience | 12 Years |
Location | 1715 Dousman St, Green Bay, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598016719 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 148866-32 (Wisconsin) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Vincent Hospital-hospital Sisters-third Order Of St Francis | 5799694675 | 562 |
News Archive
The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens -; the number who have fallen into the "coverage gap" is estimated at 5 million -; amazes and frustrates health experts.
Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.
There's no reason to try legal challenges to the contraception mandate brought by religious employers who are now protected from it until HHS decides how it will try to accommodate them, government lawyers told federal appellate court judges Friday.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B.
In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.
› Verified 5 days ago
Entity Name | Prevea Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306869276 PECOS PAC ID: 0042123150 Enrollment ID: O20031106000034 |
News Archive
The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens -; the number who have fallen into the "coverage gap" is estimated at 5 million -; amazes and frustrates health experts.
Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.
There's no reason to try legal challenges to the contraception mandate brought by religious employers who are now protected from it until HHS decides how it will try to accommodate them, government lawyers told federal appellate court judges Friday.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B.
In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.
› Verified 5 days ago
Entity Name | Oneida Nation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740278308 PECOS PAC ID: 6800794074 Enrollment ID: O20031224000077 |
News Archive
The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens -; the number who have fallen into the "coverage gap" is estimated at 5 million -; amazes and frustrates health experts.
Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.
There's no reason to try legal challenges to the contraception mandate brought by religious employers who are now protected from it until HHS decides how it will try to accommodate them, government lawyers told federal appellate court judges Friday.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B.
In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.
› Verified 5 days ago
Entity Name | St Vincent Hospital-hospital Sisters-third Order Of St Francis |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285613638 PECOS PAC ID: 5799694675 Enrollment ID: O20080620000423 |
News Archive
The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens -; the number who have fallen into the "coverage gap" is estimated at 5 million -; amazes and frustrates health experts.
Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.
There's no reason to try legal challenges to the contraception mandate brought by religious employers who are now protected from it until HHS decides how it will try to accommodate them, government lawyers told federal appellate court judges Friday.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B.
In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Natalie Larson, Po Box 19070, Green Bay, WI 54307-9070 Ph: (920) 496-4700 | Natalie Larson, 1715 Dousman St, Green Bay, WI 54303-3211 Ph: (920) 496-4700 |
News Archive
The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens -; the number who have fallen into the "coverage gap" is estimated at 5 million -; amazes and frustrates health experts.
Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.
There's no reason to try legal challenges to the contraception mandate brought by religious employers who are now protected from it until HHS decides how it will try to accommodate them, government lawyers told federal appellate court judges Friday.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B.
In a recent study by researchers in Mexico, Russia and Spain, silver nanoparticles (AgNPs) were found to inhibit SARS-CoV-2 in healthcare workers. They propose a non-pharmaceutical public health intervention consisting of mouthwash and nose rinse with an AgNPs solution to reduce morbidity among healthcare personnel exposed to the SARS-CoV-2 virus.
› Verified 5 days ago
Renee R Smith, CNM,APNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 720 S Vanburen St, Suite 101, Green Bay, WI 54301 Phone: 920-433-3420 Fax: 920-338-6859 | |
Kelly E O'connor, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1860 Shawano Ave, Green Bay, WI 54303 Phone: 920-496-4700 | |
Nylene Brittain, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2641 Development Dr, Green Bay, WI 54311 Phone: 920-338-6868 Fax: 920-338-6969 | |
Angela M Walker, CNM, APNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 720 S Vanburen St, Green Bay, WI 54301 Phone: 920-468-3444 Fax: 920-432-6313 | |
Mary Katherine Williams, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1715 Dousman St, Green Bay, WI 54303 Phone: 920-496-4700 | |
Erin Joanne Broda, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1821 S Webster Ave, Green Bay, WI 54301 Phone: 920-496-4700 |